Old Web
English
Sign In
Acemap
>
authorDetail
>
David K. Hong
David K. Hong
University of Chicago
Biology
Immunology
Cytotoxic T cell
T-cell receptor
T cell
3
Papers
664
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies
2007
Molecular Cancer Therapeutics
Ravi Salgia
David K. Hong
Steven Sherman
Chann Ng
John Frye
Linda Janish
Mark J. Ratain
Razelle Kurzrock
Show All
Source
Cite
Save
Citations (11)
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)
2000
Journal of Immunology
Matthew D. Griffin
David K. Hong
Philmore O. Holman
Kyung Mi Lee
Matthew J. Whitters
Sean O'Herrin
Francesca Fallarino
Mary Collins
David M. Segal
Thomas F. Gajewski
David M. Kranz
Jeffrey A. Bluestone
Show All
Source
Cite
Save
Citations (65)
Molecular basis of T cell inactivation by CTLA-4.
1998
Science
Kyung Mi Lee
Ellen Chuang
Matthew D. Griffin
Roli Khattri
David K. Hong
Weiguo Zhang
David Straus
Lawrence E. Samelson
Craig B. Thompson
Jeffrey A. Bluestone
Show All
Source
Cite
Save
Citations (588)
1